Dr. Stanley Freeman – Fungal diseases of medical cannabis and non-chemical methods for inflorescence decontamination

June 2022

Dr. Stanley Freeman is a senior researcher of plant pathology at the Agricultural Research Organization (ARO), The Volcani Center, Israel, where he has worked primarily on fruit crop diseases since 1993. Dr. Freeman obtained his Ph.D in plant pathology from the Hebrew University of Jerusalem, Israel in 1991, and was awarded a BARD postdoctoral fellowship to conduct research at the University of California Riverside, USA, from 1991-93. His expertise encompasses the fields of molecular plant-pathogen interactions of Fusarium, Colletotrichum, and other fungal species. Over the past 5 years, he has been involved in identifying fungal pathogens affecting medical cannabis and managing causal agents of disease. He has published over 100 peer-reviewed articles, 30 articles in conference proceedings, 15 book chapters, and edited two books. He frequently presents his research accomplishments at international conferences, at other scientific meetings, and to local growers. He is the Co-Editor in Chief of the Journal ‘Phytoparasitica‘, and served as the President of the Israeli Phytopathological Society from 2013-2017.

Previous Webinars

Carrie Cuttler, PHD.

12 September 2024, 1:00PM MST

Chronic and Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition

Dr. Carrie Cuttler received her Ph.D. in Psychology at the University of British Columbia (UBC) and subsequently conducted a post-doctoral fellowship in the Department of Psychiatry at UBC. She is currently an Associate Professor and Director of […]

Read More »

Dmitry Kurouski, PhD

Raman spectroscopy-assisted diagnosis of cannabis physiological differences

Dmitry Kurouski earned his MS in Biochemistry from Belarusian State University, Belarus and PhD (Distinguished Dissertation) in Analytical Chemistry from SUNY Albany, NY, USA. After a Postdoc in the laboratory of Professor Richard P. Van Duyne at Northwestern University, Dr Kurouski joined BoehringerIngelheim Pharmaceuticals, where he worked […]

Read More »

Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has […]

Read More »

Felipe Sarmiento Salazar, PhD

Flowering modulation in Cannabis sp. by night
interruption

June 19, 2024 11:00AM MT

Dr. Felipe Sarmiento Salazar is a biologist graduated from the Universidad de los Andes, doctor in Biology from the University of Freiburg and professor at the Department of Biology of the National University of Colombia since 2016. Professor Sarmiento has extensive experience in […]

Read More »

Ken Olejar, PhD

Cannabinoid extraction and modification: Current and future trends

May 15th, 11:00 AM MST

Dr Ken Olejar is a Research Associate at Colorado State University – Pueblo and the founder of AgriBioactive Consulting. He obtained his MSc in Pharmaceutical Science from the University of Florida and his PhD in Analytical Chemistry from The University of Auckland, New […]

Read More »

Ethan Russo, MD

Limonene, THC, Herbal Synergy and the Entourage Effect

June 13, 2024, 1:00PM MT

Ethan Russo, MD, is a board-certified child and adult neurologist(1987), psychopharmacologist, and Founder/CEO of CReDO Science. He is also Chief Medical Officer to Andira Pharmaceuticals, Senior Medical Advisor to Canurta, and Medical Director of Breeder’s Best. He was Director of R&D for the […]

Read More »